The real-life early and continuative response to Galcanezumab in chronic migraine: 3-month analysis of the multicenter prospective cohort GARLIT study

被引：0

作者：

Altamura, C. ^{[1
]}

Brunelli, N. ^{[1
]}

Costa, C. M. ^{[1
]}

Aurilia, C. ^{[2
]}

Egeo, G. ^{[2
]}

Fofi, L. ^{[2
]}

Favoni, V. ^{[3
]}

Pierangeli, G. ^{[3
]}

Messina, R. ^{[4
]}

Filippi, M. ^{[4
]}

Colombo, B. ^{[4
]}

Lovati, C. ^{[5
]}

Aguggia, M. ^{[6
]}

Bertuzzo, D. ^{[6
]}

D'Onofrio, F. ^{[7
]}

Doretti, A. ^{[8
,9
]}

Di Fiore, P. ^{[10
]}

Frediani, F. ^{[10
]}

Finocchi, C. ^{[11
]}

Rao, R. ^{[12
]}

Di Cola, F. Schiano

Bono, F. ^{[13
]}

Ranieri, A. ^{[14
]}

Albanese, M. ^{[15
]}

Cevoli, S. ^{[3
]}

Barbanti, P. ^{[2
]}

Vernieri, F. ^{[1
]}

机构：

[1] Campus Biomed Univ Rome, Neurol, Rome, Italy

[2] IRCCS San Raffaele Pisana, Headache & Pain Unit, Rome, Italy

[3] IRCCS Ist Sci Neurol Bologna, Bologna, Italy

[4] Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst, Neurol Unit, Milan, Italy

[5] Univ Hosp L Sacco, Neurol Unit, Milan, Italy

[6] Asti Hosp, Neurol & Stroke Unit, Asti, Italy

[7] Giuseppe Moscati Hosp, Neurol Unit, Avellino, Italy

[8] IRCCS, Ist Auxol Italiano, Stroke Unit, Neurol, Milan, Italy

[9] Lab Neurosci, Milan, Italy

[10] San Carlo Borromeo Hosp, ASST Santi Paolo & Carlo Milan, Headache Ctr, Neurol & Stroke Unit, Milan, Italy

[11] Osped Policlin San Martino, IRCCS, Genoa, Italy

[12] Univ Brescia, Dept Clin & Expt Sci, Neurol Unit, Brescia, Italy

[13] AOU Mater Domini, Neurol Unit, Catanzaro, Italy

[14] A Cardarelli Hosp, Headache Ctr, Neurol & Stroke Unit, Naples, Italy

[15] Univ Hosp Rome Tor Vergata, Dept Syst Med, Rome, Italy

来源：

JOURNAL OF HEADACHE AND PAIN | 2021年 / 22卷 / SUPPL 1期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P0343

引用

页码：123 / 123

页数：1

共 50 条

[1] The real-life early and continuative response to Galcanezumab in chronic migraine: 3-month analysis of the multicenter prospective cohort GARLIT study
Altamura, C.
Brunelli, N.
Costa, C. M.
Aurilia, C.
Egeo, G.
Fofi, L.
Favoni, V.
Pierangeli, G.
Messina, R.
Filippi, M.
Colombo, B.
Lovati, C.
Aguggia, M.
Bertuzzo, D.
D'Onofrio, F.
Doretti, A.
Di Fiore, P.
Frediani, F.
Finocchi, C.
Rao, R.
Di Cola, F. Schiano
Bono, F.
Ranieri, A.
Albanese, M.
Cevoli, S.
Barbanti, P.
Vernieri, F.
CEPHALALGIA, 2021, 41 (1_SUPPL) : 183 - 184
[2] Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study
Vernieri, Fabrizio
Altamura, Claudia
Brunelli, Nicoletta
Costa, Carmelina Maria
Aurilia, Cinzia
Egeo, Gabriella
Fofi, Luisa
Favoni, Valentina
Lovati, Carlo
Bertuzzo, Davide
D'Onofrio, Florindo
Doretti, Alberto
Di Fiore, Paola
Finocchi, Cinzia
Di Cola, Francesca Schiano
Ranieri, Angelo
Colombo, Bruno
Bono, Francesco
Albanese, Maria
Cevoli, Sabina
Barbanti, Piero
EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (04) : 1198 - 1208
[3] GalcanezumAb for prevention of high frequency episodic and chronic migraine in the Real Life in ITaly: a multicenter prospective cohort study (the GARLIT study)
Vernieri, F.
Altamura, C.
Brunelli, N.
Costa, C. M.
Aurilia, C.
Egeo, G.
Fofi, L.
Favoni, V.
Pierangeli, G.
Lovati, C.
Aguggia, M.
Bertuzzo, D.
D'Onofrio, F.
Doretti, A.
Di Fiore, P.
Frediani, F.
Finocchi, C.
Rao, R.
Di Cola, F. Schiano
Bono, F.
Ranieri, A.
Albanese, M.
Cevoli, S.
Barbanti, P.
CEPHALALGIA, 2021, 41 (1_SUPPL) : 29 - 30
[4] Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
Vernieri, Fabrizio
Altamura, Claudia
Brunelli, Nicoletta
Costa, Carmelina Maria
Aurilia, Cinzia
Egeo, Gabriella
Fofi, Luisa
Favoni, Valentina
Pierangeli, Giulia
Lovati, Carlo
Aguggia, Marco
d'Onofrio, Florindo
Doretti, Alberto
Di Fiore, Paola
Finocchi, Cinzia
Rao, Renata
Bono, Francesco
Ranieri, Angelo
Albanese, Maria
Cevoli, Sabina
Barbanti, Piero
JOURNAL OF HEADACHE AND PAIN, 2021, 22 (01):
[5] Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
Fabrizio Vernieri
Claudia Altamura
Nicoletta Brunelli
Carmelina Maria Costa
Cinzia Aurilia
Gabriella Egeo
Luisa Fofi
Valentina Favoni
Giulia Pierangeli
Carlo Lovati
Marco Aguggia
Florindo d’Onofrio
Alberto Doretti
Paola Di Fiore
Cinzia Finocchi
Renata Rao
Francesco Bono
Angelo Ranieri
Maria Albanese
Sabina Cevoli
Piero Barbanti
The Journal of Headache and Pain, 2021, 22
[6] Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study
Vernieri, Fabrizio
Brunelli, Nicoletta
Marcosano, Marilena
Aurilia, Cinzia
Egeo, Gabriella
Lovati, Carlo
Favoni, Valentina
Perrotta, Armando
Maestrini, Ilaria
Rao, Renata
d'Onofrio, Luigi
Finocchi, Cinzia
Aguggia, Marco
Bono, Francesco
Ranieri, Angelo
Albanese, Maria
Di Piero, Vittorio
Cevoli, Sabina
Altamura, Claudia
Barbanti, Piero
EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (01) : 224 - 234
[7] Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)
Fabrizio Vernieri
Claudia Altamura
Cinzia Aurilia
Nicoletta Brunelli
Gabriella Egeo
Luisa Fofi
Carmelina Maria Costa
Adriana Fallacara
Valentina Favoni
Giulia Pierangeli
Marco Aguggia
Davide Bertuzzo
Maria Albanese
Paola Di Fiore
Fabio Frediani
Sabina Cevoli
Piero Barbanti
Neurological Sciences, 2020, 41 : 487 - 488
[8] Galcanezumab for prevention of episodic and chronic migraine in real life in Colombia and Mexico: a multicenter prospective cohort study
Munoz-Ceron, J.
Velez, K.
Rodriguez, I.
Hernandez, N.
Guerra, C.
Bohorquez, S.
Jimenez, J. D.
Moreno, C.
Ramos, M.
Cavanzo, P.
Rojas, Y.
Bernal, R.
Lopez, R.
Gallo, L.
JOURNAL OF HEADACHE AND PAIN, 2024, 25
[9] Rapid response to galcanezumab and predictive factors in chronic migraine patients: a 3-month observa-tional, longitudinal, cohort, multicenter, Italian real-life study(vol 29,pg 1198,2022)
Vernieri, F.
Altamura, C.
Brunelli, N.
EUROPEAN JOURNAL OF NEUROLOGY, 2023,
[10] Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)
Vernieri, Fabrizio
Altamura, Claudia
Aurilia, Cinzia
Brunelli, Nicoletta
Egeo, Gabriella
Fofi, Luisa
Costa, Carmelina Maria
Fallacara, Adriana
Favoni, Valentina
Pierangeli, Giulia
Aguggia, Marco
Bertuzzo, Davide
Albanese, Maria
Di Fiore, Paola
Frediani, Fabio
Cevoli, Sabina
Barbanti, Piero
NEUROLOGICAL SCIENCES, 2020, 41 (SUPPL 2) : 487 - 488

← 1 2 3 4 5 →